InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Kramer Robin. Officer active across 1 company, notably BIOGEN INC.. Cumulatively, 19 filings have been published. History available since 1 July 2021. The latest transaction was filed on 6 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kramer Robin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
789 股0Common StockSEC:0000875045-26-000021:0
834 股0Common StockSEC:0001127602-25-004457:0
788 股0Common StockSEC:0001127602-25-003958:0
351 股0Common StockSEC:0001127602-24-028860:0
914 股0Common StockSEC:0001127602-24-006215:0
833 股0Common StockSEC:0001127602-24-004797:0
788 股0Common StockSEC:0001127602-24-004306:0
351 股0Common StockSEC:0001127602-23-029441:0
252 股0Common StockSEC:0001127602-23-020236:0
512 股0Common StockSEC:0001127602-23-006519:0
833 股0Common StockSEC:0001127602-23-005270:0
887 股0Common StockSEC:0001127602-23-002487:0
350 股0Common StockSEC:0001127602-22-027340:0
252 股0Common StockSEC:0001127602-22-019021:0
396 股0Common StockSEC:0001127602-22-006271:0
99 股0Common StockSEC:0001127602-22-004987:0
244 股0Common StockSEC:0001127602-22-001861:0
74 股@ US$223.9216.5% 占其流量Common StockSEC:0001127602-21-030462:0
251 股@ US$348.9283.5% 占其流量Common StockSEC:0001127602-21-021266:0
19 条申报中的 19 条
About Kramer Robin
Kramer Robin is a declarant linked to BIOGEN INC. (XNAS), where the listed role is Chief Financial Officer. They have 19 filings in total, and across the 19 sampled filings, the observed dates run from 2021-07-02 to 2026-02-10, with a modal transaction nature of option exercise and buy and sell volumes of EUR 0 each.
